MPM BioVentures 2018, 10% Owner: Aktis Oncology AKTS Buy · Filed 01/14

Trade details

Type: Insider buy
Amount: $20,029,986
Shares · price: 1,112,777 sh · $18.00 a share
Held after: 10,260,064 sh
Stock: Aktis Oncology AKTS
Person: MPM BioVentures 201810% Owner
Trade date: 26/01/12
Filed: 26/01/14
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 17 insiders
Holding change: +12.2%

Aktis Oncology trades, last 26 weeks

What else happened in Aktis Oncology around then

Filed or reported within 30 days of the trade day · 25/12/13~02/11

MPM BioVentures 2018's recent trades

MPM BioVentures 2018Other
SelliTeos Therapeutics
Sell
iTeos Therapeutics
ITOS
$5.1M
630,191 sh
$5.1M
Filed 25/05/15
Traded 25/05/13
MPM BioVentures 201810% Owner
SellEntrada Therapeutics
Sell
Entrada Therapeutics
TRDA
$476.4K
22,935 sh
$476.4K
Filed 24/12/12
Traded 24/12/10
MPM BioVentures 201810% Owner
SellEntrada Therapeutics
Sell
Entrada Therapeutics
TRDA
$440.8K
21,787 sh
$440.8K
Filed 24/12/12
Traded 24/12/11